Shuichi Ohuchida

2.6k citations

57 papers · 2.1k indexed · h-index 20

Pharmacology top 0.5%
- Inflammatory mediators and NSAID effects 36
Biochemistry top 1%
- Eicosanoids and Hypertension Pharmacology 11
Genetics top 5%
- Estrogen and related hormone effects 13
Organic Chemistry top 5%
- Synthesis and Biological Evaluation 9
- Synthesis of β-Lactam Compounds 7
Cancer Research top 10%
Molecular Biology
- Chemical Synthesis and Analysis 14
Pharmaceutical Science
- Fluorine in Organic Chemistry 5
Physiology
- Asthma and respiratory diseases 5

Co-authors: Takayuki Maruyama Shuh Narumiya Toshihiko Kawamori Takashi Sügimura Kouji Watanabe Kigen Kondo Keiji Wakabayashi Fumitaka Ushikubi
Cited by: Pharmacology Biochemistry Genetics
Journals: Proceedings of the National Academy of Sciences (1 paper)Journal of the American Chemical Society (2 papers)Biochemical and Biophysical Research Communications (1 paper)
Partner nations: Japan United Kingdom United States

In The Last Decade

Shuichi Ohuchida

57 papers receiving 2.1k citations

Peers

Countries citing papers authored by Shuichi Ohuchida

Since Specialization

Citations

This map shows the geographic impact of Shuichi Ohuchida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuichi Ohuchida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuichi Ohuchida more than expected).

Fields of papers citing papers by Shuichi Ohuchida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuichi Ohuchida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuichi Ohuchida. The network helps show where Shuichi Ohuchida may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shuichi Ohuchida, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shuichi Ohuchida Line = papers co-authored together Shuichi Ohuchida links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 2: Optimization of the side chains to improve in vitro and in vivo potencies Bioorganic & Medicinal Chemistry ·Masaki Asada,Maki Iwahashi,Tetsuo Obitsu,Atsushi Kinoshita,Yoshihiko Nakai,Takahiro Onoda,Toshihiko Nagase,Motoyuki Tanaka,Yoshiyuki Yamaura,Hiroya Takizawa,Ken Yoshikawa,Kazutoyo Sato,Masami Narita,Shuichi Ohuchida,Hisao Nakai,Masaaki Toda	2010	13
2	Discovery of novel N-acylsulfonamide analogs as potent and selective EP3 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Masaki Asada,Tetsuo Obitsu,Atsushi Kinoshita,Yoshihiko Nakai,Toshihiko Nagase,Isamu Sugimoto,Motoyuki Tanaka,Hiroya Takizawa,Ken Yoshikawa,Kazutoyo Sato,Masami Narita,Shuichi Ohuchida,Hisao Nakai,Masaaki Toda	2010	20
3	3-(2-Aminocarbonylphenyl)propanoic acid analogs as potent and selective EP3 receptor antagonists. Part 1: Discovery and exploration of the carboxyamide side chain Bioorganic & Medicinal Chemistry ·Masaki Asada,Tetsuo Obitsu,Toshihiko Nagase,Motoyuki Tanaka,Yoshiyuki Yamaura,Hiroya Takizawa,Ken Yoshikawa,Kazutoyo Sato,Masami Narita,Shuichi Ohuchida,Hisao Nakai,Masaaki Toda	2009	13
4	Suppression of azoxymethane‐induced colon cancer development in rats by a prostaglandin E receptor EP₁‐selective antagonist Cancer Science ·Naoko Niho,Michihiro Mutoh,Tomohiro Kitamura,Mami Takahashi,Hidetaka Sato,Hiroshi Yamamoto,Takayuki Maruyama,Shuichi Ohuchida,Takashi Sügimura,Keiji Wakabayashi	2005	23
5	Development of a prostaglandin D2 receptor antagonist: discovery of a new chemical lead European Journal of Medicinal Chemistry ·Kazuhiko Torisu,Kaoru Kobayashi,Maki Iwahashi,Hiromu Egashira,Yoshihiko Nakai,Yutaka Okada,Fumio Nanbu,Shuichi Ohuchida,Hisao Nakai,Masaaki Toda	2005	14
6	Up-regulation of lymphocytic cholinergic activity by ONO-4819, a selective prostaglandin EP4 receptor agonist, in MOLT-3 human leukemic T cells Vascular Pharmacology ·Aya Suenaga,Takeshi Fujii,Hiroshi Ogawa,Takayuki Maruyama,Shuichi Ohuchida,Nobuo Katsube,Takaaki Obata,Koichiro Kawashima	2004	15
7	Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists Bioorganic & Medicinal Chemistry ·Kazuhiko Torisu,Kaoru Kobayashi,Maki Iwahashi,Yoshihiko Nakai,Takahiro Onoda,Toshihiko Nagase,Isamu Sugimoto,Yutaka Okada,Ryoji Matsumoto,Fumio Nanbu,Shuichi Ohuchida,Hisao Nakai,Masaaki Toda	2004	15
8	Combined effects of prostaglandin E receptor subtype EP₁ and subtype EP₄ antagonists on intestinal tumorigenesis in adenomatous polyposis coli gene knockout mice Cancer Science ·Tomohiro Kitamura,Masaki Itoh,Tetsuo Noda,Kousuke Tani,Michiyoshi Kobayashi,Takayuki Maruyama,Kaoru Kobayashi,Shuichi Ohuchida,Takashi Sügimura,Keiji Wakabayashi	2003	42
9	Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation Proceedings of the National Academy of Sciences ·Keiji Yoshida,Hiroji Oida,Takuya Kobayashi,Takayuki Maruyama,Masaharu Tanaka,Teruaki Katayama,Kojiro Yamaguchi,Eri Segi‐Nishida,Tadao Tsuboyama,Mutsumi Matsushita,Kosei Ito,Yoshiaki Ito,Yukihiko Sugimoto,Fumitaka Ushikubi,Shuichi Ohuchida,Kigen Kondo,Takashi Nakamura,Shuh Narumiya	2002	273
10	Design and synthesis of a selective EP4-receptor agonist. Part 4: practical synthesis and biological evaluation of a novel highly selective EP4-receptor agonist Bioorganic & Medicinal Chemistry ·Toru Maruyama,Shin‐itsu Kuwabe,Yasufumi Kawanaka,Tai Shiraishi,Yoshiyuki Shinagawa,Kiyoto Sakata,Akiteru Seki,Yoko Kishida,Hideyuki Yoshida,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Shinsuke Hashimoto,Masanori Kawamura,Kigen Kondo,Masaaki Toda	2002	21
11	Development of a highly selective EP2-receptor agonist. Part 2: identification of 16-Hydroxy-17,17-trimethylene 9β-chloro PGF derivatives Bioorganic & Medicinal Chemistry ·Kousuke Tani,Atsushi Naganawa,Akiharu Ishida,Hiromu Egashira,Kenji Sagawa,Hiroyuki Harada,Mikio Ogawa,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Kigen Kondo,Masaaki Toda	2002	13
12	Development of a highly selective EP2-receptor agonist. Part 1: identification of 16-hydroxy-17,17-trimethylene PGE2 derivatives Bioorganic & Medicinal Chemistry ·Kousuke Tani,Atsushi Naganawa,Akiharu Ishida,Kenji Sagawa,Hiroyuki Harada,Mikio Ogawa,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Kigen Kondo,Masaaki Toda	2002	16
13	Prevention of Diabetic Nephropathy in Rats by Prostaglandin E Receptor EP1-Selective Antagonist Journal of the American Society of Nephrology ·Hisashi Makino,Issei Tanaka,Masashi Mukoyama,Akira Sugawara,Kiyoshi Mori,Seiji Muro,Takayoshi Suganami,Kensei Yahata,Rieko Ishibashi,Shuichi Ohuchida,Takayuki Maruyama,Shuh Narumiya,Kazuwa Nakao	2002	96
14	Design and synthesis of a selective EP4-Receptor agonist. Part 1: discovery of 3,7-DithiaPGE1 derivatives and identification of Their ω chains Bioorganic & Medicinal Chemistry ·Toru Maruyama,Masaki Asada,Tai Shiraishi,Hiromu Egashira,Hideyuki Yoshida,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Kigen Kondo,Masaaki Toda	2002	4
15	Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP1 antagonist, on breast cancer development Carcinogenesis ·Toshihiko Kawamori,Naoaki Uchiya,Seiichi Nakatsugi,Kouji Watanabe,Shuichi Ohuchida,Hiroshi Yamamoto,Takayuki Maruyama,Kigen Kondo,T Sugimura,Keiji Wakabayashi	2001	76
16	Design and Synthesis of a Highly Selective EP2-Receptor Agonist Bioorganic & Medicinal Chemistry Letters ·Kousuke Tani,Atsushi Naganawa,Akiharu Ishida,Hiromu Egashira,Kenji Sagawa,Hiroyuki Harada,Mikio Ogawa,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Kigen Kondo,Masaaki Toda	2001	37
17	Design and synthesis of a highly selective EP4-receptor agonist. Part 2: 5-thia and 9β-haloPG derivatives with improved stability Bioorganic & Medicinal Chemistry Letters ·Toru Maruyama,Masaki Asada,Tai Shiraishi,Kiyoto Sakata,Akiteru Seki,Hideyuki Yoshida,Yoshiyuki Shinagawa,Takayuki Maruyama,Shuichi Ohuchida,Hisao Nakai,Kigen Kondo,Masaaki Toda	2001	11
18	Inhibitory effect of a prostaglandin E receptor subtype EP1 selective antagonist, ONO-8713, on development of azoxymethane-induced aberrant crypt foci in mice Cancer Letters ·Kouji Watanabe,Toshihiko Kawamori,Seiichi Nakatsugi,Toshihisa Ohta,Shuichi Ohuchida,Hiroshi Yamamoto,Takayuki Maruyama,Kigen Kondo,Shuh Narumiya,Takashi Sügimura,Keiji Wakabayashi	2000	99
19	Synthesis of 9α,11α-thiathromboxane A2 methyl ester Tetrahedron Letters ·Shuichi Ohuchida,Nobuyuki Hamanaka,Shinsuke Hashimoto,Masaki Hayashi	1982	4
20	Synthesis of thromboxane A2 analog DL-(9,11), (11,12)-dideoxa-(9,11)-epithio-(11,12)-methylene-thromboxane A2 Tetrahedron Letters ·Shuichi Ohuchida,Nobuyuki Hamanaka,Masaki Hayashi	1981	12

About Shuichi Ohuchida

Shuichi Ohuchida is a scholar working on Pharmacology, Biochemistry and Organic Chemistry, having authored 57 papers that have together received 2.1k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (36 papers), Chemical Synthesis and Analysis (14 papers), Estrogen and related hormone effects (13 papers), Eicosanoids and Hypertension Pharmacology (11 papers), Synthesis and Biological Evaluation (9 papers), Synthesis of β-Lactam Compounds (7 papers), Fluorine in Organic Chemistry (5 papers) and Asthma and respiratory diseases (5 papers). The work is most often cited by research in Pharmacology (1.2k citations), Biochemistry (360 citations) and Genetics (573 citations). Shuichi Ohuchida has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Takayuki Maruyama, Shuh Narumiya, Toshihiko Kawamori, Takashi Sügimura, Kouji Watanabe, Kigen Kondo, Keiji Wakabayashi, Fumitaka Ushikubi, Hiroshi Yamamoto and Yukihiko Sugimoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact